In conclusion, the molecular connections illustrate how CD133+ colorectal cancer cells enhance their survival and maintain their stem cell-like characteristics by inhibiting critical apoptotic pathways, thereby rendering them resistant to conventional treatments. The gene discussed is PROM1; the disease is colorectal cancer.